After the advent of the heart-lung machine, which permitted open-heart surgery, in 1953, valve surgery was one of the most important advances in cardiac surgery. Initially, only conservative procedures were possible, but the first orthotopic human implantation of an artificial valve, by Starr in 1960, permitted the replacement of most cardiac valves not amenable to repair. Since then, more than a million and a half patients have had valve replacement using countless models of prostheses. However, the complications related to valve prostheses, often resulting in the patient's death, led to the development of valvuloplasty techniques, especially of the mitral valve, pioneered by Carpentier 1 and Duran in the early 1970s. 2 The results of mitral valve conservation have been clearly superior to those of replacement, especially in degenerative mitral insufficiency.
However, the valve areas achieved are not as large as those reported for the surgical procedure, 10 although good long-term results have been reported by some groups. 11 Much more recently, the percutaneous transcatheter approach to mitral valve regurgitation has been explored. In the last two to three decades, mitral valvuloplasty performed as an open-heart procedure has gained much popularity. The most important techniques involved in this operation are correction of leaflet prolapse and annuloplasty of the dilated/deformed annulus. Exceptionally good results have been reported, especially for degenerative disease. 12 Recently, the feasibility of the edge-to-edge repair (Alfieri) by a metal clip mounted in the tip of a catheter was demonstrated and is being applied by some groups. 13 On the other hand, annuloplasty devices placed in the coronary sinus during cardiac catheterisation have been developed, 14 but the anatomy of the coronary sinus is variable and its relationship with the mitral annulus is not constant. 15 Not unexpectedly, these methods have not yet met expectations and, for the time being, patients with mitral valve regurgitation benefit the most from conventional surgery, independent of the use of the minimal-access techniques described above. In contrast to the mitral valve, the majority of the aortic valves cannot be repaired and require replacement. Recently, a new approach to heart valve intervention has arisen in the form of replacement by a valve attached to the tip of a catheter introduced from a peripheral artery or vein. This method was initially used for replacement of the pulmonary valve and good results were obtained by several authors. 16 This procedure is facilitated by easy access via a peripheral vein and by the less essential nature of the pulmonary valve, as moderate dysfunction of this valve is relatively well tolerated.
The natural sequence of this experience was the extension to the aortic valve, 17 but this valve is far less tolerant to even moderate degrees of dysfunction. Positioning of the prosthesis is here far more difficult, and peri-prosthetic leakage and the potential for coronary obstruction are the main drawbacks. This procedure is so far used only in so-called compassionate cases. 18 However, because the concept of valve replacement without opening the heart is appealing, the percutaneous transcatheter approach is being challenged by a transapical approach, which has the advantage of a much easier and more accurate positioning because of the shorter way to the valve. 19 Several types of self-expanding valves have been developed for this type of utilisation, but the procedure remains experimental. 20 A similar approach is being sought for mitral valve replacement, but positioning is here even more difficult than for the aortic valve. 21 
Conclusion
Until recently, the principles of valve surgery have remained mostly unchanged since the early 1960s. Valve conservation and replacement have specific indications and the results are generally good. Newer valve prostheses are more efficient and somewhat less thrombogenic and it is difficult to conceive that major advances will be around the corner. The new devices being developed for catheter-based procedures do not conform to widely accepted standards applied for over four decades with the classic prostheses. 22 Hence, it is to be expected that it will take some time before transcatheter valve repair and replacement may reach general use. However, progress has undoubtedly been made in decreasing the invasiveness of conventional valve surgery, and it is conceivable that in the future a significant number of these valve procedures may be performed with the resulting diminution of surgical trauma and improved comfort to the patient. ■
